ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Colorectal Screening Rates Lower In Safety Net System

September 25, 2009

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980

Cancer Meetings Listed For May and June

April 23, 1993

It’s Official; Most of NCI NTP contingent Will Move To N.C.

February 22, 1980

President Accepts Rauscher Resignation

October 1, 1976